Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis.
ASMD
Fabry
Gaucher
cytokine
lysosomal storage diseases
natural language processing
systems biology
text-mining
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
04
2021
accepted:
30
07
2021
entrez:
7
9
2021
pubmed:
8
9
2021
medline:
8
9
2021
Statut:
epublish
Résumé
Lysosomal storage diseases (LSDs) are characterized by the abnormal accumulation of substrates in tissues due to the deficiency of lysosomal proteins. Among the numerous clinical manifestations, chronic inflammation has been consistently reported for several LSDs. However, the molecular mechanisms involved in the inflammatory response are still not completely understood. In this study, we performed text-mining and systems biology analyses to investigate the inflammatory signals in three LSDs characterized by sphingolipid accumulation: Gaucher disease, Acid Sphingomyelinase Deficiency (ASMD), and Fabry Disease. We first identified the cytokines linked to the LSDs, and then built on the extracted knowledge to investigate the inflammatory signals. We found numerous transcription factors that are putative regulators of cytokine expression in a cell-specific context, such as the signaling axes controlled by STAT2, JUN, and NR4A2 as candidate regulators of the monocyte Gaucher disease cytokine network. Overall, our results suggest the presence of a complex inflammatory signaling in LSDs involving many cellular and molecular players that could be further investigated as putative targets of anti-inflammatory therapies.
Identifiants
pubmed: 34490253
doi: 10.3389/fcell.2021.703489
pmc: PMC8417786
doi:
Types de publication
Journal Article
Langues
eng
Pagination
703489Informations de copyright
Copyright © 2021 Parolo, Tomasoni, Bora, Ramponi, Kaddi, Azer, Domenici, Neves-Zaph and Lombardo.
Déclaration de conflit d'intérêts
CK and SN-Z are current employees of Sanofi and may hold shares and/or stock options in the company. KA was employee of Sanofi while the initial phase of this study was conducted. SP, RL, DT, PB, and ED were contracted by Sanofi while the initial phase of this study was conducted. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Database (Oxford). 2016 Nov 25;2016:
pubmed: 27888231
Sci Data. 2018 Feb 27;5:180015
pubmed: 29485622
Database (Oxford). 2015 Apr 15;2015:bav028
pubmed: 25877637
Trends Cardiovasc Med. 2007 May;17(4):129-33
pubmed: 17482095
Nat Rev Drug Discov. 2018 Feb;17(2):133-150
pubmed: 29147032
Orphanet J Rare Dis. 2013 Sep 11;8:140
pubmed: 24020503
J Neuroinflammation. 2016 May 12;13(1):104
pubmed: 27175482
J Inherit Metab Dis. 2013 May;36(3):543-53
pubmed: 22976765
EMBO Mol Med. 2015 Oct 29;7(12):1529-46
pubmed: 26516212
Mol Genet Metab. 2020 Sep - Oct;131(1-2):245-252
pubmed: 32620536
Mol Genet Metab. 2018 Jul;124(3):189-203
pubmed: 30017653
BMC Bioinformatics. 2018 Feb 07;19(1):37
pubmed: 29415654
Crit Rev Oncog. 2013;18(3):197-220
pubmed: 23510064
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
CPT Pharmacometrics Syst Pharmacol. 2018 Jul;7(7):442-452
pubmed: 29920993
Pediatr Cardiol. 2010 Jan;31(1):30-2
pubmed: 19784695
Nat Rev Drug Discov. 2018 Mar;17(3):151-152
pubmed: 29242613
Curr Clin Pharmacol. 2018;13(3):199-208
pubmed: 29866013
Hum Mol Genet. 2009 Apr 15;18(8):1482-8
pubmed: 19193629
Virus Res. 2016 Jun 15;218:40-8
pubmed: 26673098
Brief Bioinform. 2016 Jan;17(1):132-44
pubmed: 25935162
Orphanet J Rare Dis. 2019 Dec 2;14(1):275
pubmed: 31791361
Immunol Lett. 2017 Aug;188:79-85
pubmed: 28687233
J Comput Assist Tomogr. 2002 Sep-Oct;26(5):843-8
pubmed: 12439326
Mol Genet Metab. 2021 Feb;132(2):86-93
pubmed: 33077353
Acta Neuropathol Commun. 2020 Aug 24;8(1):144
pubmed: 32831144
Trends Pharmacol Sci. 2021 Apr;42(4):255-267
pubmed: 33563480
Front Neurosci. 2015 Oct 30;9:417
pubmed: 26578874
Nat Genet. 2003 Jan;33(1):85-9
pubmed: 12496759
BMC Nephrol. 2014 May 06;15:72
pubmed: 24886109
Sci Rep. 2018 Jan 9;8(1):157
pubmed: 29317695
PLoS One. 2020 Jun 15;15(6):e0233956
pubmed: 32542027
Gene. 1997 Jul 31;194(2):201-13
pubmed: 9272862
JMIR Med Inform. 2018 Oct 10;6(4):e11301
pubmed: 30305261
Int J Mol Sci. 2017 Feb 17;18(2):
pubmed: 28218669
PLoS One. 2019 Jan 11;14(1):e0210617
pubmed: 30633777
Nucleic Acids Res. 2018 Oct 12;46(18):9321-9337
pubmed: 30184180
Mol Neurodegener. 2019 Aug 29;14(1):36
pubmed: 31464647
Methods Mol Biol. 2019;1939:231-252
pubmed: 30848465
Bioinformatics. 2016 Sep 15;32(18):2839-46
pubmed: 27283952
Bioinformatics. 2013 Nov 15;29(22):2909-17
pubmed: 23969135
Semin Immunol. 2018 Jun;37:30-42
pubmed: 29478824
Nucleic Acids Res. 2020 Dec 2;48(21):12055-12073
pubmed: 33179750
Am J Hematol. 2012 Apr;87(4):377-83
pubmed: 22388998
PLoS One. 2012;7(9):e43232
pubmed: 23028447
PLoS Comput Biol. 2018 Feb 15;14(2):e1005962
pubmed: 29447159
Bioinformatics. 2020 Jan 1;36(1):295-302
pubmed: 31243432
Brief Bioinform. 2021 Jul 20;22(4):
pubmed: 33147626
Int J Mol Sci. 2020 Dec 28;22(1):
pubmed: 33379210
Biomed Res Int. 2015;2015:918710
pubmed: 26380306
Front Physiol. 2021 Mar 25;12:637999
pubmed: 33841175
Mol Genet Metab. 2017 Jan - Feb;120(1-2):27-33
pubmed: 28164782
Crit Rev Oncog. 2013;18(3):235-46
pubmed: 23510066
Nat Rev Genet. 2021 Feb;22(2):71-88
pubmed: 33168968
Nat Biotechnol. 2018 Aug;36(7):651-659
pubmed: 29912209
Ther Clin Risk Manag. 2018 Oct 24;14:2069-2080
pubmed: 30498352
Clin Rheumatol. 2010 Sep;29(9):1037-41
pubmed: 20419464
JMIR Med Inform. 2020 Jun 12;8(6):e17353
pubmed: 32530430
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Blood Cells Mol Dis. 2018 Feb;68:21-29
pubmed: 27856178
Stem Cell Reports. 2017 Dec 12;9(6):1853-1867
pubmed: 29198828
Mol Genet Metab. 2004 Sep-Oct;83(1-2):6-15
pubmed: 15464415
Blood Cells Mol Dis. 2018 Feb;68:185-191
pubmed: 28126395
Bioinformatics. 2007 Jul 15;23(14):1862-5
pubmed: 17495998
Blood Cells Mol Dis. 2011 Jan 15;46(1):92-4
pubmed: 20920864
Transl Neurodegener. 2021 Jan 15;10(1):4
pubmed: 33446243
Ann Neurol. 2012 Sep;72(3):455-63
pubmed: 23034917
Mol Biosyst. 2016 Feb;12(2):477-9
pubmed: 26661513
Microbiome. 2018 Sep 21;6(1):171
pubmed: 30241567
CPT Pharmacometrics Syst Pharmacol. 2020 Jul;9(7):374-383
pubmed: 32558397
BMC Bioinformatics. 2020 Oct 26;21(Suppl 5):250
pubmed: 33106154
Nature. 2017 Mar 2;543(7643):108-112
pubmed: 28225753
PLoS One. 2015 May 15;10(5):e0126153
pubmed: 25978039
Nat Rev Dis Primers. 2018 Oct 1;4(1):27
pubmed: 30275469